Armata Pharmaceuticals Inc. (ARMP)
$7.41
$-0.95
(-11.36%)
As on 11-Jun-2026 15:51EDT
Market cap
$282 Mln
Revenue (TTM)
$5 Mln
P/E Ratio
--
P/B Ratio
4.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-34.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
15.7
-
Debt to Equity
-1.1
-
Book Value
$--
-
EPS
$-7.8
-
Face value
--
-
Shares outstanding
36,710,810
10 Years Aggregate
CFO
$-188.85 Mln
EBITDA
$-230.97 Mln
Net Profit
$-192.19 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Armata Pharmaceuticals (ARMP)
| 18.0 | -10.7 | -38.0 | 263.2 | 72.2 | 11.8 | -29.2 |
|
BSE Sensex
| -12.8 | -4.5 | -5.6 | -10.4 | 5.6 | 7.1 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Armata Pharmaceuticals (ARMP)
| 239.5 | -42.6 | 161.3 | -77.4 | 83.6 | -8.2 | 12.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Armata Pharmaceuticals (ARMP)
|
7.4 | 282.3 | 5.2 | -282.6 | -3,134.7 | -- | -- | 4.1 |
| 291.6 | 40,461.0 | 4,286.9 | 577.2 | 9.8 | 88.2 | 76.3 | 37.6 | |
| 217.5 | 13,001.6 | 867.5 | 506.6 | -2.8 | -- | 23.9 | 23.8 | |
| 53.9 | 13,246.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 17.5 | 6.8 | |
| 179.7 | 30,617.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 22.8 | 5.0 | |
| 470.0 | 11,227.7 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 20.9 | |
| 475.5 | 12,973.2 | 2,678.3 | 460.4 | 21.1 | 103.2 | 28.6 | 21.9 | |
| 614.1 | 66,620.0 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 15.5 | 2.1 | |
| 548.2 | 23,340.2 | 3,169.8 | 1,287.4 | 51.4 | 20.6 | 20.3 | 4.0 | |
| 445.2 | 113,407.9 | 12,255.1 | 4,338.3 | 31.7 | 23.7 | 26.5 | 5.9 |
Shareholding Pattern
View DetailsAbout Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary... bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. Read more
-
Chief Medical Officer
Dr. Mina Pastagia M.D., MS
-
CEO & Director
Dr. Deborah L. Birx M.D.
-
Headquarters
Los Angeles, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Armata Pharmaceuticals (ARMP)
What is the current share price of Armata Pharmaceuticals Inc (ARMP) Today?
The share price of Armata Pharmaceuticals Inc (ARMP) is $7.41 (NYSE) as of 11-Jun-2026 15:51 EDT. Armata Pharmaceuticals Inc (ARMP) has given a return of 72.25% in the last 3 years.
What is the current PB & PE ratio of Armata Pharmaceuticals Inc (ARMP)?
Since, TTM earnings of Armata Pharmaceuticals Inc (ARMP) is negative, P/E ratio is not available.
The P/B ratio of Armata Pharmaceuticals Inc (ARMP) is 4.06 times as on 05-Jun-2026, a 0 discount to its peers’ median range of 4.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.31
|
-1.04
|
|
2024
|
-5.78
|
-2.28
|
|
2023
|
-1.69
|
-3.65
|
|
2022
|
-1.21
|
1.24
|
|
2021
|
-6.23
|
5.68
|
What is the 52 Week High and Low of Armata Pharmaceuticals Inc (ARMP)?
The 52-week high and low of Armata Pharmaceuticals Inc (ARMP) are Rs 16.34 and Rs 1.75 as of 12-Jun-2026.
What is the market cap of Armata Pharmaceuticals Inc (ARMP)?
Armata Pharmaceuticals Inc (ARMP) has a market capitalisation of $ 282 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Armata Pharmaceuticals Inc (ARMP)?
Before investing in Armata Pharmaceuticals Inc (ARMP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.